Current Clinical Trials
The following is a list of clinical trials that are currently enrolling patients. These trials are conducted by
Division of Gastroenterology faculty and/or in conjunction with our multi-disciplinary partners in affiliated departments,
with areas of research spanning a wide range of topics, from hepatitis C to Barrett’s Esophagus. This list is updated
periodically as new clinical trials become available for enrollment.
All clinical trials are posted on the
University of Washington’s Health Sciences Research Studies
website along with important information about participating in clinical trials, such as
Common Research Terms,
Phases of a Clinical Trial, and
Questions About Participating in a Research Study.
The overall aim of this study is to better understand why people with fat and inflammation in the liver
that is not due to drinking alcohol, are at increased risk for diabetes. This condition is called non-alcoholic
steatohepatitis and is diagnosed by liver biopsy. We are trying to understand why people with this condition do
not use glucose as well as healthy subjects and if certain medications can decrease fat and inflammation in the
liver and improve how the body uses glucose.
The overall aim of this study is to determine the effect of diet composition (high fat versus low fat)
on the liver and health factors that may increase the risk of diabetes. In addition, we will examine the effect of
diet composition on inflammation and fat biology.
The current, standard treatment for pancreatic cancer is surgery to remove the cancer. The purpose of this study
is to determine whether or not adding chemotherapy and radiation treatments to the standard treatment of surgery will
delay (or stop) the return of pancreatic cancer.
The purpose of this study is to find out if the study drug ABI-007 given together with another drug,
Gemcitabine (a drug approved for the treatment of pancreatic cancer), is as safe and effective as Gemcitabine
alone in patients with metastatic pancreas cancer.